Bookmark?Remove?
Novartis wins CHMP nod for drug combo against some lung cancers
The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel, Switzerland January 25, 2017. REUTERS/Arnd Wiegmann Swiss drugmaker Novartis’s drugs Tafinlar and Mekinist edged closer to approval in Europe to be used together against a type of lu... More »
